MIR31HG and hepatocellular carcinoma: To evaluate the biological effect of MIR31HG on HCC development, plasmid expressing MIR31HG (pcDNA3.1-MIR31HG) and shRNA inhibiting MIR31HG (sh-MIR31HG) were constructed and their efficiencies were confirmed (Additional file 2: Figure S1a).